Bacitracin Zinc Ointment Recall: Med Pride 0.9g packets
Announced 2026-06-24 · FDA
FDA is recalling Med Pride Bacitracin Zinc Ointment due to CGMP deviations observed during an FDA inspection. The recall involves about 1087 tubes distributed nationwide in the United States, covering lots 007, 008, 009, 015, and 016 and within expiry. Corrective action information was not provided.
| Brand | Dabur India Limited |
|---|---|
| Product | Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 count box, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30352 4. |
| Reason | CGMP Deviations; deficiencies observed during FDA inspection |
| Severity | moderate |
| Units affected | 4944 |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot# 007, 008, 009, 015, 016, Within Expiry. |
WHAT YOU SHOULD DO
- Stop using any units from lots 007, 008, 009, 015, or 016 and keep the packaging for reference.
- Contact the retailer or Shield Line LLC for instructions on return, disposal, or refund.
- If you have questions, contact Dabur India Limited/Med Pride or Shield Line LLC for guidance.
- If you have experienced any adverse effects, seek medical advice.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.